Thursday, August 27, 2026
26.2 C
Bengaluru

Dr. Rishubh Gupta has been appointed Head of Subregion Africa for Roche Diagnostics

Dr. Rishubh Gupta has been appointed Head of Subregion Africa for Roche Diagnostics, effective August 1, 2026. In his new role, he will be based in Nairobi, Kenya, and join the EMEA-LATAM Leadership Team.

Over the past three years, Dr. Gupta has led Roche Diagnostics’ India and Neighboring Markets operations with a strong focus on expanding diagnostic access, driving patient-centered innovation, and delivering measurable impact across the healthcare ecosystem. His leadership has contributed significantly to organizational growth and strengthened the company’s commitment to improving patient outcomes.

Reflecting on his tenure, Dr. Gupta said:
“It has been a privilege to lead the India and Neighboring Markets team, and I am confident that the organisation will continue to drive strong impact and sustainable growth under Marco’s leadership.”

MedicinMan congratulates Dr. Rishubh Gupta and wishes him all the best as he takes on this important regional leadership role.

Hot this week

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

How To See Dr Reddy’s Nestle In The Wellness Shift

GLP-1 medicines such as semaglutide and tirzepatide are changing...

How To Power The India Biopharma Regulatory Revolution Now

Beyond the Pharmacy of the World: Why India's Biopharma...

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Topics

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

How To See Dr Reddy’s Nestle In The Wellness Shift

GLP-1 medicines such as semaglutide and tirzepatide are changing...

How To Power The India Biopharma Regulatory Revolution Now

Beyond the Pharmacy of the World: Why India's Biopharma...

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...
spot_img

Related Articles

spot_imgspot_img